You are herePharma News

Pharma News

Simple Breath can Diagnose Esophageal And Gastric Cancer

Esophageal and gastric malignancies account for 15 percent of cancer-related deaths globally. British researchers have developed a breath test that can detect oesophageal and gastric (stomach) cancer in minutes with 90 percent accuracy. The test has produced encouraging results in a clinical study of 210 patients, and will now be tested in a larger trial involving three hospitals in London. The study was published in the journal Annals of Surgery.

Researcher found Too much vitamin B12 may promote acne

The researchers looked at the bacteria's gene expression  and find link between vitamin B12 and  acne. In the presence of vitamin B12, the skin bacteria that are commonly linked to acne start pumping out inflammatory molecules known to promote pimples.Propionibacterium acnes, the most common skin microbe, causes pimples in some people but not in others. In humans, vitamin B12 plays a key role in metabolism, red blood cell formation and the maintenance of the central nervous system and is found in multivitamins. The study was published in the journal Science Translational Medicine.

Ebola Virus Disease can be diagnosed by New 'Finger-Prick Test' Within Minutes

A diagnostic test for Ebola can accurately predict within minutes if an individual has Ebola Virus Disease (EVD). The study is published in The Lancet.

Blood Test may Detect Pancreatic Cancer at early stage

Scientists, including one of the Indian-origin, have found a blood test effective in detecting early pancreatic cancer in human as it is often diagnosed in the later stages. The report appeared in the journal Nature.

World Health Organization stated: Insecticide Lindane, DDT may Cause Cancer

The World Health Organization (WHO) has revealed that lindane, an insecticide, widely used in agriculture and to treat human lice and scabies, can cause cancer and associated to occurrence of non-Hodgkin lymphoma, a rare kind of cancer. International Agency for Research in Cancer (IARC's)  specialist panel classified lindane as "carcinogenic to humans" in its Group 1 category, DDT as "probably carcinogenic to humans" in its Group 2A class, and the herbicide 2,4-D as "possibly carcinogenic to humans" in its Group 2B.

Skin Cancer Drug may Slow Age-Related Deaths

Scientist  have found that a drug used to treat skin cancer may slow the onset of age-related deaths by slowing the aging process in fruit flies. The study was printed in the journal Cell.

Ricoh India present ‘Picasso’ medical imaging solution in Hyderabad

Ricoh India, a wholly-owned subsidiary of Japanese imaging and electronics major Ricoh, launched  a new medical imaging solution called ‘Picasso’ (Patient is Central to this Advanced Solution and Service Offering) recently in Hyderabad. Picaso is web-based multi-specialty cloud-enabled imaging solution. The new innovative medical imaging solution is designed to offer benefits to patients, radiologists, consultants and hospitals and drastic reduction in the healthcare costs for the patients.

Head and Neck Cancers can be detected by New Test That Uses Blood and Saliva

Head and neck cancers affect nearly 50,000 people in the United States each year. The main risk factors include alcohol, smoking and human papillomavirus (HPV), a common sexually transmitted infection that often goes undetected. Researchers at Johns Hopkins University have developed a new test that uses blood and saliva to detect head and neck cancers.  The research is published in Science Translational Medicine.

1mg unveils 'Doctors by 1mg' on National Doctors Day

(NewsVoir);, India’s leading m-health platform, today launched ‘Doctors by 1mg’ on the Android platform, to help Delhi NCR discover best doctors and book appointments. A companion to the 1mg App which is the leading consumer health platform with over 3 M downloads, the new launch demonstrates company’s commitment towards building a platform that will aid users in managing their health effectively.

Jubilant's anti-infection drug receive US regulator nod

Jubilant Life Sciences has announced that it had received approval of the US Food and Drug Administration (FDA) for its tablets used in treating adults for various infections, including pneumonia. The market size for Levofloxacin is estimated to be $28 million (Rs.179 crore) per annum.